C3.2.16. Vaccines and immunization

Outline the conclusions that can be drawn from the graph showing data for PCV and S. pneumoniae.

Outline the conclusions that can be drawn from the graph showing data for PCV and S. pneumoniae.

Outline the conclusions that can be drawn from the graph showing data for PCV and S. pneumoniae.

Outline the conclusions that can be drawn from the graph showing data for PCV and S. pneumoniae.

Outline the conclusions that can be drawn from the graph showing data for PCV and S. pneumoniae.

Outline the conclusions that can be drawn from the graph showing data for PCV and S. pneumoniae.

Suggest reasons for the difference between the data for S. pneumoniae and H. influenzae.

Suggest reasons for the difference between the data for S. pneumoniae and H. influenzae.

Suggest reasons for the difference between the data for S. pneumoniae and H. influenzae.

Suggest reasons for the difference between the data for S. pneumoniae and H. influenzae.

Suggest reasons for the difference between the data for S. pneumoniae and H. influenzae.

Suggest reasons for the difference between the data for S. pneumoniae and H. influenzae.

Using the data in the violin plots, deduce the age range at which children are most likely to develop ARI due to S. pneumoniae.

Using the data in the violin plots, deduce the age range at which children are most likely to develop ARI due to S. pneumoniae.

Using the data in the violin plots, deduce the age range at which children are most likely to develop ARI due to S. pneumoniae.

Using the data in the violin plots, deduce the age range at which children are most likely to develop ARI due to S. pneumoniae.

Using the data in the violin plots, deduce the age range at which children are most likely to develop ARI due to S. pneumoniae.

Using the data in the violin plots, deduce the age range at which children are most likely to develop ARI due to S. pneumoniae.

Suggest reasons for the difference between the fraction attributed to S. pneumoniae in all cases of ARI and in cases where antibiotics were used to treat the infection.

Suggest reasons for the difference between the fraction attributed to S. pneumoniae in all cases of ARI and in cases where antibiotics were used to treat the infection.

Suggest reasons for the difference between the fraction attributed to S. pneumoniae in all cases of ARI and in cases where antibiotics were used to treat the infection.

Suggest reasons for the difference between the fraction attributed to S. pneumoniae in all cases of ARI and in cases where antibiotics were used to treat the infection.

Suggest reasons for the difference between the fraction attributed to S. pneumoniae in all cases of ARI and in cases where antibiotics were used to treat the infection.

Suggest reasons for the difference between the fraction attributed to S. pneumoniae in all cases of ARI and in cases where antibiotics were used to treat the infection.

When there is no vaccination, the estimated number of cases for lower-middle income countries is larger than in either low income or upper-middle income countries. Suggest one reason for this.

When there is no vaccination, the estimated number of cases for lower-middle income countries is larger than in either low income or upper-middle income countries. Suggest one reason for this.

When there is no vaccination, the estimated number of cases for lower-middle income countries is larger than in either low income or upper-middle income countries. Suggest one reason for this.

When there is no vaccination, the estimated number of cases for lower-middle income countries is larger than in either low income or upper-middle income countries. Suggest one reason for this.

When there is no vaccination, the estimated number of cases for lower-middle income countries is larger than in either low income or upper-middle income countries. Suggest one reason for this.

When there is no vaccination, the estimated number of cases for lower-middle income countries is larger than in either low income or upper-middle income countries. Suggest one reason for this.

Using the data, predict the effect of universal PCV vaccination in LMICs.

Using the data, predict the effect of universal PCV vaccination in LMICs.

Using the data, predict the effect of universal PCV vaccination in LMICs.

Using the data, predict the effect of universal PCV vaccination in LMICs.

Using the data, predict the effect of universal PCV vaccination in LMICs.

Using the data, predict the effect of universal PCV vaccination in LMICs.

Outline likely health benefits of universal PCV vaccination of children, other than reducing the incidence of ARI.

Outline likely health benefits of universal PCV vaccination of children, other than reducing the incidence of ARI.

Outline likely health benefits of universal PCV vaccination of children, other than reducing the incidence of ARI.

Outline likely health benefits of universal PCV vaccination of children, other than reducing the incidence of ARI.

Outline likely health benefits of universal PCV vaccination of children, other than reducing the incidence of ARI.

Outline likely health benefits of universal PCV vaccination of children, other than reducing the incidence of ARI.